XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Beginning balance at May. 01, 2021 $ 918.0 $ 19.8 $ 157.6 $ 6.1 $ (11.5) $ 746.0
Beginning balance (in shares) at May. 01, 2021   39,644,913        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of tax withholding (0.3) $ 0.1 (0.1)     (0.3)
Issuance of restricted stock, net of tax withholding (in shares)   44,245        
Exercise of stock options 0.5   0.5      
Exercise of stock options (in shares)   13,000        
Purchases of common stock $ (63.7) $ (0.7)       (63.0)
Purchases of common stock (in shares) (1,425,190) (1,425,190)        
Stock-based compensation expense $ 8.4   8.4      
Other comprehensive income (loss) (16.7)     (16.7)    
Net income 86.0         86.0
Dividends on common stock (15.8)         (15.8)
Ending balance at Jan. 29, 2022 916.4 $ 19.2 166.4 (10.6) (11.5) 752.9
Ending balance (in shares) at Jan. 29, 2022   38,276,968        
Beginning balance at Oct. 30, 2021 919.5 $ 19.4 163.8 (2.0) (11.5) 749.8
Beginning balance (in shares) at Oct. 30, 2021   38,737,129        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchases of common stock $ (21.3) $ (0.2)       (21.1)
Purchases of common stock (in shares) (460,161) (460,161)        
Stock-based compensation expense $ 2.6   2.6      
Other comprehensive income (loss) (8.6)     (8.6)    
Net income 29.4         29.4
Dividends on common stock (5.2)         (5.2)
Ending balance at Jan. 29, 2022 916.4 $ 19.2 166.4 (10.6) (11.5) 752.9
Ending balance (in shares) at Jan. 29, 2022   38,276,968        
Beginning balance at Apr. 30, 2022 913.8 $ 19.2 169.0 (26.8) (11.5) 763.9
Beginning balance (in shares) at Apr. 30, 2022   38,276,968        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of tax withholding (0.4)         (0.4)
Issuance of restricted stock, net of tax withholding (in shares)   63,643        
Exercise of stock options 1.5   1.5      
Exercise of stock options (in shares)   40,000        
Purchases of common stock $ (39.6) $ (0.6)       (39.0)
Purchases of common stock (in shares) (1,005,514) (1,005,514)        
Stock-based compensation expense $ 8.4   8.4      
Other comprehensive income (loss) 5.2     (5.2)    
Net income 69.0         69.0
Dividends on common stock (15.3)         (15.3)
Ending balance at Jan. 28, 2023 942.6 $ 18.6 178.9 (21.6) (11.5) 778.2
Ending balance (in shares) at Jan. 28, 2023   37,375,097        
Beginning balance at Oct. 29, 2022 898.8 $ 18.7 174.7 (54.3) (11.5) 771.2
Beginning balance (in shares) at Oct. 29, 2022   37,505,633        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock, net of tax withholding (in shares)   9,164        
Exercise of stock options 1.5   1.5      
Exercise of stock options (in shares)   40,000        
Purchases of common stock $ (8.0) $ (0.1)       (7.9)
Purchases of common stock (in shares) (179,700) (179,700)        
Stock-based compensation expense $ 2.7   2.7      
Other comprehensive income (loss) 32.7     32.7    
Net income 19.9         19.9
Dividends on common stock (5.0)         (5.0)
Ending balance at Jan. 28, 2023 $ 942.6 $ 18.6 $ 178.9 $ (21.6) $ (11.5) $ 778.2
Ending balance (in shares) at Jan. 28, 2023   37,375,097